US Equity
GMAB
— Genmab A/SGenmab is a biotechnology company that develops differentiated antibody therapeutics for the treatment of cancer and other serious diseases using its proprietary antibody technologies.
💰 Market cap: $17.96B📍 Carl Jacobsens Vej 30, VALBY, 2500 DK🏷️ Biotechnology & Medical Research💵 Previous close: $28.87🔢 7,570 credits left
Add Column
All
Trend
| Date ▾ | Close ▾ |
|---|---|
| 2026-07-24 | $28.87 |
| 2026-07-23 | $29.17 |
| 2026-07-22 | $28.85 |
| 2026-07-21 | $28.36 |
| 2026-07-20 | $27.91 |
| 2026-07-17 | $28.72 |
| 2026-07-16 | $28.98 |
| 2026-07-15 | $29.08 |
| 2026-07-14 | $28.73 |
| 2026-07-13 | $28.80 |
| 2026-07-10 | $29.00 |
| 2026-07-09 | $29.78 |
| 2026-07-08 | $29.54 |
| 2026-07-07 | $29.18 |
| 2026-07-06 | $28.01 |
| 2026-07-02 | $28.52 |
| 2026-07-01 | $27.64 |
| 2026-06-30 | $27.47 |
| 2026-06-29 | $26.02 |
| 2026-06-26 | $26.12 |
| 2026-06-25 | $26.14 |
| 2026-06-24 | $25.86 |
| 2026-06-23 | $25.94 |
| 2026-06-22 | $25.61 |
| 2026-06-18 | $25.27 |
| 2026-06-17 | $25.39 |
| 2026-06-16 | $24.74 |
| 2026-06-15 | $24.58 |
| 2026-06-12 | $25.08 |
| 2026-06-11 | $25.24 |
| 2026-06-10 | $24.49 |
| 2026-06-09 | $25.10 |
| 2026-06-08 | $24.80 |
| 2026-06-05 | $25.15 |
| 2026-06-04 | $24.73 |
| 2026-06-03 | $23.88 |
| 2026-06-02 | $23.85 |
| 2026-06-01 | $25.45 |
| 2026-05-29 | $26.33 |
| 2026-05-28 | $27.04 |
| 2026-05-27 | $26.71 |
| 2026-05-26 | $26.89 |
| 2026-05-22 | $26.87 |
| 2026-05-21 | $27.05 |
| 2026-05-20 | $27.21 |
| 2026-05-19 | $25.68 |
| 2026-05-18 | $26.37 |
| 2026-05-15 | $26.54 |
| 2026-05-14 | $26.90 |
| 2026-05-13 | $26.55 |
| 2026-05-12 | $27.09 |
| 2026-05-11 | $26.18 |
| 2026-05-08 | $26.43 |
| 2026-05-07 | $27.06 |
| 2026-05-06 | $27.89 |
| 2026-05-05 | $27.52 |
| 2026-05-04 | $27.04 |
| 2026-05-01 | $26.45 |
| 2026-04-30 | $26.52 |
| 2026-04-29 | $26.11 |
| 2026-04-28 | $26.79 |